MoneyWorks4Me

Windlas Biotech informs about daily report

10 Jan 2023 Evaluate

Pursuant to provisions of Regulation 18(i) of the Buy-back Regulations, Windlas Biotech has submitted the daily report with respect to Equity Shares bought back by the Company on January 10, 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1759.80
Dr. Reddys Labs. 1245.00
Cipla 1328.80
Lupin 1904.50
Zydus Lifesciences 1128.70
View more..